Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisak

Showing results (491-500 of 529) with videos related to

Pageof 53
Sort By:
Leukemia Research|May 6, 1999
Biologic characteristics of patients with hypocellular myelodysplastic syndromesR Goyal, H Qawi, I Ali, et al.
Viruses|January 28, 2026
Genetic Diversity of Tick-Borne Encephalitis Virus in KyrgyzstanLeyla H Shigapova, Irina V Kozlova, Galya V Klink, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2000
Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study GroupK P Johnson, B R Brooks, C C Ford, et al.
Chemosphere|December 6, 2021
The properties of particleboard composites made from three sorghum (Sorghum bicolor) accessions using maleic acid adhesiveJajang Sutiawan, Yusuf Sudo Hadi, Deded Sarip Nawawi, et al.
Waste Management (New York, N.Y.)|June 14, 2025
High temperature slagging gasification demonstration-scale trial of sewage sludge: Feasibility analysis towards mono treatment, operational challenges and life-cycle assessmentMei Ping Vernette Chin, Wei Ping Chan, Yinn Zhao Boon, et al.
Journal of Neuroinflammation|July 10, 2012
Effects of dimethyl fumarate on neuroprotection and immunomodulationPhilipp Albrecht, Imane Bouchachia, Norbert Goebels, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2003
Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trialK P Johnson, B R Brooks, C C Ford, et al.
Physical Review Letters|August 8, 2022
Subpromille Measurements and Calculations of CO (3-0) Overtone Line IntensitiesKatarzyna Bielska, Aleksandra A Kyuberis, Zachary D Reed, et al.
Scientific Reports|December 8, 2015
Absolute measurement of the 1S0 - 3P0 clock transition in neutral 88Sr over the 330 km-long stabilized fibre optic linkPiotr Morzyński, Marcin Bober, Dobrosława Bartoszek-Bober, et al.
Journal of the Neurological Sciences|September 27, 2020
COVID-19 in multiple sclerosis patients and risk factors for severe infectionFarhan Chaudhry, Helena Bulka, Anirudha S Rathnam, et al.
Pageof 53

Showing results (491-500 of 529) with videos related to

Sort By:
Pageof 53
Leukemia Research|May 6, 1999
Biologic characteristics of patients with hypocellular myelodysplastic syndromesR Goyal, H Qawi, I Ali, et al.
Viruses|January 28, 2026
Genetic Diversity of Tick-Borne Encephalitis Virus in KyrgyzstanLeyla H Shigapova, Irina V Kozlova, Galya V Klink, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2000
Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study GroupK P Johnson, B R Brooks, C C Ford, et al.
Chemosphere|December 6, 2021
The properties of particleboard composites made from three sorghum (Sorghum bicolor) accessions using maleic acid adhesiveJajang Sutiawan, Yusuf Sudo Hadi, Deded Sarip Nawawi, et al.
Waste Management (New York, N.Y.)|June 14, 2025
High temperature slagging gasification demonstration-scale trial of sewage sludge: Feasibility analysis towards mono treatment, operational challenges and life-cycle assessmentMei Ping Vernette Chin, Wei Ping Chan, Yinn Zhao Boon, et al.
Journal of Neuroinflammation|July 10, 2012
Effects of dimethyl fumarate on neuroprotection and immunomodulationPhilipp Albrecht, Imane Bouchachia, Norbert Goebels, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2003
Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trialK P Johnson, B R Brooks, C C Ford, et al.
Physical Review Letters|August 8, 2022
Subpromille Measurements and Calculations of CO (3-0) Overtone Line IntensitiesKatarzyna Bielska, Aleksandra A Kyuberis, Zachary D Reed, et al.
Scientific Reports|December 8, 2015
Absolute measurement of the 1S0 - 3P0 clock transition in neutral 88Sr over the 330 km-long stabilized fibre optic linkPiotr Morzyński, Marcin Bober, Dobrosława Bartoszek-Bober, et al.
Journal of the Neurological Sciences|September 27, 2020
COVID-19 in multiple sclerosis patients and risk factors for severe infectionFarhan Chaudhry, Helena Bulka, Anirudha S Rathnam, et al.
Pageof 53